Global pharmaceutical manufacturer focused on cardiology, oncology, and neurology
Servier is a 20,000+ person pharmaceutical group headquartered in France with medicines distributed across 130+ countries. The company operates a foundation-governed structure and invests nearly 20% of brand-name sales into R&D. Current hiring is heavily weighted toward sales (36 roles) and healthcare functions (12 roles), with notable focus on regulatory and medical-writing leadership — a mix that reflects both commercial scaling and the clinical-stage intensity of oncology and neurology pipeline expansion.
Notable leadership hires: Medical Writing Lead, Regulatory Lead, Oral Solid Drug Lead
Servier is an independent, foundation-governed pharmaceutical manufacturer with core strength in cardiology and venous diseases, now scaling oncology and neurology portfolios through precision medicine. The group generated €6.9 billion in revenue in the 2024/25 financial year and operates manufacturing, R&D, and commercial functions across 15+ countries. Active projects center on product launches, patient advocacy implementation, clinical development strategy, and geographic market expansion. Compliance, resource allocation, and overseas territory growth rank among internal operational priorities.
Servier runs Microsoft Office, Excel, PowerPoint, SAP S/4HANA, Salesforce, Oracle Database, Veeva, IQVIA, Power BI, Tableau, SAP, Azure Data Factory, Python, Haskell, and PL/SQL across operations and analytics.
Servier is headquartered in Suresnes, France, and distributes medicines in more than 130 countries. Current hiring spans 15 territories including the US, France, Japan, Brazil, Hungary, Belgium, Switzerland, Germany, and Latin American countries.
Other companies in the same industry, closest in size